Related Experiment Video
Updated: Aug 15, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Ethical considerations in presymptomatic testing for variant CJD
R E Duncan1, M B Delatycki, S J Collins
1Murdoch Children's Research Institute and the Bruce Lefroy Centre for Genetic Health Research, Royal Children's Hospital, Parkville, Australia.
Insights
Variant Creutzfeldt-Jakob disease (vCJD) is a fatal neurodegenerative disorder with no current treatment. New diagnostic tests raise ethical questions about patient autonomy versus public health, proposing compulsory screening for high-risk individuals.
Area of Science:
- Neurodegenerative Diseases
- Transmissible Spongiform Encephalopathies
- Public Health Ethics
Background:
- Variant Creutzfeldt-Jakob disease (vCJD) is a fatal, untreatable neurodegenerative disorder.
- vCJD transmission is linked to bovine spongiform encephalopathy and human blood transfusions.
- Presymptomatic diagnosis is crucial due to potential future epidemics.
Purpose of the Study:
- To elaborate on the ethical implications of developing presymptomatic diagnostic tests for vCJD.
- To compare vCJD testing ethics with predictive genetic testing for Huntington's disease and HIV screening.
- To propose a testing paradigm balancing personal autonomy with societal protection.
Main Methods:
- Ethical analysis of diagnostic test availability.
- Comparative ethical framework with Huntington's disease and HIV screening.
- Development of a proposed testing paradigm for vCJD.
Main Results:
- The availability of reliable, non-invasive vCJD diagnostic tests presents significant ethical challenges.
- Balancing individual autonomy with public health obligations is paramount.
- A paradigm for vCJD testing is proposed, drawing parallels with HIV screening.
Conclusions:
- Compulsory testing of blood/organ donors and high-risk surgical patients is proposed.
- The proposed paradigm includes unique features for vCJD screening.
- Ethical considerations necessitate careful deliberation on who to test for vCJD.
Abstract:
Variant Creutzfeldt-Jakob disease (vCJD) is a fatal, transmissible, neurodegenerative disorder for which there is currently no effective treatment. vCJD arose from the zoonotic spread of bovine spongiform encephalopathy. There is now compelling evidence for human to human transmission through blood transfusions from presymptomatic carriers and experts are warning that the real epidemic may be yet to come. Imperatives exist for the development of reliable, non-invasive presymptomatic diagnostic tests. Research into such tests is well advanced. In this article the ethical implications of the availability of these tests are elaborated and comparisons drawn with predictive genetic testing for Huntington's disease and screening for HIV. Paramount to considerations is the issue of whom to test, weighing up respect for personal autonomy against obligations to benefit and protect society. A paradigm is proposed similar to that used for HIV screening but with unique features: compulsory testing of all blood/organ donors and individuals undergoing surgery or invasive procedures who have a significant risk of disease transmission.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Single Nucleotide Polymorphisms-SNPs
Bias in Epidemiological Studies
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
